Safety of intravitreous fomivirsen for treatment of cytomegalovirus retinitis in patients with AIDS
- 30 April 2002
- journal article
- clinical trial
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 133 (4), 484-498
- https://doi.org/10.1016/s0002-9394(02)01332-6
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Immune-recovery uveitisPublished by Oxford University Press (OUP) ,2005
- Randomized dose-comparison studies of intravitreous fomivirsen for treatment of cytomegalovirus retinitis that has reactivated or is persistently active despite other therapies in patients with AIDSAmerican Journal of Ophthalmology, 2002
- A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with aids1American Journal of Ophthalmology, 2002
- Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implantBrazilian Journal of Medical and Biological Research, 2000
- Decreased visual acuity in patients with cytomegalovirus retinitis and AIDSEye, 2000
- Ocular complications of intravenous cidofovir for cytomegalovirus retinitis in patients with AIDSEye, 1999
- High-dose (2000-μg) intravitreous ganciclovir in the treatment of cytomegalovirus retinitis11The authors have no financial interest in the drugs or methods described in this article.Ophthalmology, 1998
- Effect of Antisense Oligonucleotides on Cytokine Release from Human Keratinocytes in anin VitroModel of SkinToxicology and Applied Pharmacology, 1996
- Distribution of cytokine proteins within epiretinal membranes in proliferative vitreoretinopathyCurrent Eye Research, 1994
- Management of Cytomegalovirus Disease with Antiviral DrugsClinical Infectious Diseases, 1990